Regenerative Potential of Stem and Progenitor Cells from Ischemic Testes of C57Bl/6 Mice in Culture and in the Model of Spermatogenesis Suppression Caused by Busulfan


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

The regenerative potential of stem and progenitor cells from ischemic testes of C57Bl/6 mice was studied in vitro (cell culture) and in vivo (mouse model of busulfan-induced suppression of spermatogenesis). Spermatogonial stem cells with phenotypes CD117CD90+ and CD51CD24+CD52+ from ischemic testes demonstrated 33-fold and 7-fold increments of cell mass and generated colonies in vitro. Epithelial (CD45CD31Sca-1+CD49f+) and endothelial (CD45CD31+) precursors exhibited lower self-renewal capacity. On day 30 after injection of stem and progenitor cells from ischemic testes to the rete testis zone of the testes of busulfantreated animals, an increase in the count of CD117CD90+ spermatogonial stem cells, total count, and mobile sperm count in the testes of recipient mice was observed. In addition, we observed an increase in Sca-1+ cell count, recovery of the spermatogenic epithelium in the seminiferous tubules, and appearance of immature Leydig cells in “busulfan” testes; the level of tissue testosterone and fertility index also increased.

About the authors

E. G. Skurikhin

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: angelinapakhomova2011@gmail.com
Russian Federation, Tomsk

A. V. Pakhomova

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Author for correspondence.
Email: angelinapakhomova2011@gmail.com
Russian Federation, Tomsk

O. V. Pershina

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: angelinapakhomova2011@gmail.com
Russian Federation, Tomsk

L. A. Ermolaeva

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: angelinapakhomova2011@gmail.com
Russian Federation, Tomsk

N. N. Ermakova

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: angelinapakhomova2011@gmail.com
Russian Federation, Tomsk

V. A. Krupin

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: angelinapakhomova2011@gmail.com
Russian Federation, Tomsk

E. S. Pan

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: angelinapakhomova2011@gmail.com
Russian Federation, Tomsk

A. I. Kudryashova

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: angelinapakhomova2011@gmail.com
Russian Federation, Tomsk

O. Yu. Rybalkina

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: angelinapakhomova2011@gmail.com
Russian Federation, Tomsk

V. V. Zhdanov

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: angelinapakhomova2011@gmail.com
Russian Federation, Tomsk

V. E. Goldberg

Tomsk Research Medical Center

Email: angelinapakhomova2011@gmail.com
Russian Federation, Tomsk

A. M. Dygai

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: angelinapakhomova2011@gmail.com
Russian Federation, Tomsk


Copyright (c) 2017 Springer Science+Business Media New York

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies